{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:43:44Z","timestamp":1788000224210,"version":"build-2784847793"},"reference-count":24,"publisher":"American Society of Hematology","issue":"4","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The leucine-rich repeat-containing G-protein\u2013coupled receptor 6 (LGR6) was recently identified as the cognate receptor for the proresolving mediator maresin 1 (MaR1). To address the biological role of LGR6 in humans, we investigated the functional impact of a genetic variant in the gene encoding for LGR6, which is predicted to lead to a frameshift mutation in one of the receptor isoforms, on both receptor expression and immune cell responses. In neutrophils, monocytes, and natural killer (NK) cells from volunteers homozygous for this variant, we found a significant downregulation in the expression of LGR6 when compared with controls without the variant; whereas the LGR6 expression was essentially similar in monocyte-derived macrophages and CD8+ T cells. Functionally, loss of LGR6 expression was linked with a decreased ability of neutrophils and monocytes to phagocytose bacteria. We observed an increase in neutrophil chemotaxis and leukotriene B4 production and increased expression of activation markers, including markers for platelet-leukocyte phagocyte heterotypic aggregates, such as CD41, in neutrophils and monocytes from the variant group. Using data from the UK Biobank, we found that at\u00a0a population level the rs4266947 variant, which is in high linkage disequilibrium with\u00a0rs74355478, was associated with a higher incidence of viral infections. Intriguingly, neutrophils, NK cells, and CD8+ T\u00a0cells from volunteers with the LGR6 variant displayed altered viral responses when stimulated with Toll-like receptor 3 (TLR3), TLR7\/TLR8, and TLR9 agonists. Together, these findings shed new light on the cell type\u2013specific regulation of LGR6 expression and the role of this receptor in directing host immune responses.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2023021826","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T19:54:47Z","timestamp":1715198087000},"page":"420-434","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["An <i>LGR6<\/i> frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-416X","authenticated-orcid":false,"given":"Esteban A.","family":"Gomez","sequence":"first","affiliation":[{"name":"1Centre for Biochemical Pharmacology, The William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-5979","authenticated-orcid":false,"given":"Roberta","family":"De Matteis","sequence":"additional","affiliation":[{"name":"1Centre for Biochemical Pharmacology, The William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2324-2849","authenticated-orcid":false,"given":"Palita","family":"Udomjarumanee","sequence":"additional","affiliation":[{"name":"1Centre for Biochemical Pharmacology, The William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4176-2947","authenticated-orcid":false,"given":"Patricia B.","family":"Munroe","sequence":"additional","affiliation":[{"name":"2Centre for Clinical Pharmacology and Precision Medicine, The William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-3640","authenticated-orcid":false,"given":"Jesmond","family":"Dalli","sequence":"additional","affiliation":[{"name":"1Centre for Biochemical Pharmacology, The William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"},{"name":"3Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2024072515203872600_bib1","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1161\/CIRCRESAHA.121.319142","article-title":"Disrupted resolution mechanisms favor altered phagocyte responses in COVID-19","volume":"129","author":"Koenis","year":"2021","journal-title":"Circ Res"},{"key":"2024072515203872600_bib2","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3389\/fimmu.2017.01921","article-title":"New insights into the immunobiology of mononuclear phagocytic cells and their relevance to the pathogenesis of cardiovascular diseases","volume":"8","author":"Sanmarco","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"2024072515203872600_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2024072515203872600_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front Immunol"},{"key":"2024072515203872600_bib5","doi-asserted-by":"crossref","first-page":"107879","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: an organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2024072515203872600_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/IAI.01131-15","article-title":"Maresin 1 biosynthesis and proresolving anti-infective functions with human-localized aggressive periodontitis leukocytes","volume":"84","author":"Wang","year":"2015","journal-title":"Infect Immun"},{"issue":"3","key":"2024072515203872600_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/ijms23031367","article-title":"Maresin-1 and inflammatory disease","volume":"23","author":"Saito-Sasaki","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2024072515203872600_bib8","doi-asserted-by":"crossref","first-page":"e2206480120","DOI":"10.1073\/pnas.2206480120","article-title":"The maresin 1-LGR6 axis decreases respiratory syncytial virus-induced lung inflammation","volume":"120","author":"Krishnamoorthy","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024072515203872600_bib9","doi-asserted-by":"crossref","first-page":"101749","DOI":"10.1016\/j.molmet.2023.101749","article-title":"Maresin\u00a01 activates brown adipose tissue and\u00a0promotes browning of white adipose tissue in mice","volume":"74","author":"Laiglesia","year":"2023","journal-title":"Mol Metab"},{"issue":"12","key":"2024072515203872600_bib10","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"W1","key":"2024072515203872600_bib11","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2024072515203872600_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nsmb.1550","article-title":"Nonsense-mediated mRNA decay (NMD) mechanisms","volume":"16","author":"Brogna","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"7571","key":"2024072515203872600_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"D1","key":"2024072515203872600_bib14","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2024072515203872600_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuron.2015.05.004","article-title":"Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles","volume":"87","author":"Raj","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"2024072515203872600_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/nar\/gkx1165","article-title":"Alternative start and termination sites of transcription drive most transcript isoform differences across human tissues","volume":"46","author":"Reyes","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2024072515203872600_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory-- pro-resolving mediators and their receptors","volume":"11","author":"Serhan","year":"2011","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"2024072515203872600_bib18","doi-asserted-by":"crossref","first-page":"105226","DOI":"10.1016\/j.isci.2022.105226","article-title":"Transcellular biosynthesis of leukotriene B4 orchestrates neutrophil swarming to fungi","volume":"25","author":"Hopke","year":"2022","journal-title":"iScience"},{"key":"2024072515203872600_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection","volume":"5","author":"Schuch","year":"2014","journal-title":"Front Immunol"},{"key":"2024072515203872600_bib20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3389\/fimmu.2020.01638","article-title":"GSK-3 inhibition as a therapeutic approach against SARs CoV2: dual benefit of inhibiting viral replication while potentiating the immune response","volume":"11","author":"Rudd","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"2024072515203872600_bib21","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1371\/journal.ppat.0030123","article-title":"Natural killer cells promote early CD8 T cell responses against cytomegalovirus","volume":"3","author":"Robbins","year":"2007","journal-title":"PLoS Pathog"},{"issue":"11","key":"2024072515203872600_bib22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/v14112445","article-title":"CXCL10 chemokine: a critical player in RNA and DNA viral infections","volume":"14","author":"Elemam","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"2024072515203872600_bib23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/iid3.500","article-title":"Role of neutrophils in acute viral infection","volume":"9","author":"Ma","year":"2021","journal-title":"Immun Inflamm Dis"},{"issue":"9","key":"2024072515203872600_bib24","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.3390\/ijms22094726","article-title":"Type I interferon-mediated regulation of antiviral capabilities of neutrophils","volume":"22","author":"Stegelmeier","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/4\/420\/2235505\/blood_bld-2023-021826-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/4\/420\/2235505\/blood_bld-2023-021826-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T15:28:03Z","timestamp":1721921283000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/4\/420\/516036\/An-LGR6-frameshift-variant-abrogates-receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023021826","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}